MedPath

Movano Health Advances EvieMED Ring Toward FDA Clearance

• Movano Health is set to respond to the FDA's clarifying questions for its EvieMED Ring, marking a crucial step in the 510(k) clearance process. • The EvieMED Ring integrates pulse oximetry with wellness metrics, such as sleep and activity tracking, to enhance clinical trials and patient monitoring. • Movano Health expresses confidence in securing FDA clearance for EvieMED, highlighting its potential to improve patient compliance and data collection.

Movano Health is moving closer to obtaining FDA 510(k) clearance for its EvieMED Ring, a wearable device that combines medical and wellness tracking features. The company plans to submit responses to the FDA's clarifying questions as part of the final review phase.
Having previously addressed initial FDA inquiries regarding EvieMED's wellness features, Movano Health is optimistic about receiving clearance. The EvieMED Ring is designed to provide both medical device functionality through pulse oximetry and comprehensive wellness metrics, including sleep, activity, and mood tracking.

Leadership Optimism

John Mastrototaro, president and CEO of Movano Health, stated, "We are pleased that we will be submitting a timely and thorough response to the agency’s questions and look forward to the successful completion of the 510(k) review process." He emphasized the potential of EvieMED to be a "game-changing device" for remote patient monitoring and clinical trials, enhancing patient compliance and data collection.

EvieMED Ring Features

The EvieMED Ring aims to improve patient compliance and data collection by integrating medical and wellness tracking in a user-friendly design. Its features include pulse oximetry for medical-grade data and tracking of sleep patterns, activity levels, mood, and energy for overall wellness monitoring.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Highlighted Clinical Trials

Related Topics

Monogram Technologies Advances mBôs TKA System Toward FDA Clearance

Monogram Technologies anticipates addressing FDA concerns regarding its mBôs TKA System without requiring clinical data, potentially accelerating the path to market.
The company plans to submit a comprehensive response to the FDA's Additional Information Request (AIR) in the first quarter of 2025.

enVVeno Medical Seeks FDA Approval for VenoValve in Severe Deep Venous CVI

enVVeno Medical has submitted its Premarket Approval (PMA) application to the FDA for VenoValve, a device to treat severe deep venous Chronic Venous Insufficiency (CVI).
The VenoValve has breakthrough device designation, and four of five PMA modules are approved, with clinical data from the SAVVE trial under review.

enVVeno Medical Seeks FDA Approval for VenoValve and Completes enVVe Study

enVVeno Medical has submitted its PMA application to the FDA for VenoValve, a breakthrough device for severe deep venous Chronic Venous Insufficiency (CVI).
The FDA is expected to make a decision on VenoValve in the second half of 2025, potentially offering a new treatment for 2.5 million U.S. candidates.

enVVeno Medical Seeks FDA Approval for VenoValve in Severe Chronic Venous Insufficiency

enVVeno Medical has submitted its Premarket Approval (PMA) application to the FDA for VenoValve, a surgical replacement venous valve.
The VenoValve is intended for treating severe deep venous Chronic Venous Insufficiency (CVI), a condition affecting approximately 2.5 million people in the U.S. annually.

Movano Health's EvieMED Ring Receives FDA Clearance for Pulse Oximetry

Movano Health has secured FDA 510(k) clearance for the pulse oximeter in its EvieMED Ring, expanding its reach into healthcare B2B opportunities.
The EvieMED Ring combines medical-grade accuracy with the comfort of a wearable, potentially improving patient compliance in health monitoring.

iRhythm Technologies Receives FDA Clearance for Zio AT Design Updates, Stock Surges

iRhythm Technologies (IRTC) secured FDA 510(k) clearance for design updates to its Zio AT cardiac monitoring device, addressing prior regulatory concerns.
The approval marks a significant step in iRhythm's ongoing efforts to meet FDA compliance and enhance the quality and safety of its Zio AT system.

Movano Health Provides Update on FDA Review of EvieMED Ring

Movano Health is actively collaborating with the FDA to secure 510(k) clearance for its EvieMED Ring, a wearable medical device.
The FDA has recently requested additional clarifying information regarding the medical aspects of the EvieMED Ring, prompting further engagement from Movano.

Monogram Technologies Receives FDA Request for Additional Information on mBôs TKA System

Monogram Technologies received an Additional Information Request (AIR) from the FDA for its mBôs TKA System, requiring a response within 180 days.
The company plans to conduct clinical trials in India to gather necessary data for the FDA submission, aiming for regulatory clearance in early Q1 2025.

FDA Finalizes Guidance on Electronic Records in Clinical Trials

The FDA has finalized guidance addressing questions about using electronic records and signatures in clinical trials, aiming to modernize data collection and management.
The guidance clarifies FDA's expectations for electronic systems, ensuring data integrity, reliability, and participant safety in clinical investigations.

AbbVie's ABBV-951 (Foscarbidopa/Foslevodopa) Receives Complete Response Letter from FDA

AbbVie received a Complete Response Letter (CRL) from the FDA for its New Drug Application for ABBV-951 (foscarbidopa/foslevodopa).
The FDA's response cited observations from a third-party manufacturer inspection, unrelated to ABBV-951 or any AbbVie medicine.

Reference News

[1]
Movano to Respond to FDA Questions as Part of EvieMED Final Review Phase
sleepreviewmag.com · Oct 28, 2024

Movano Health plans to submit responses to FDA's clarifying questions for EvieMED Ring's 510(k) clearance, combining med...

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy